Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Effectiveness of Calcium Polycarbophil in IBS-C
ChiCTR2600128405Phase 4Not yet recruiting
- Sponsor
- Ningbo No. 2 Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of calcium polycarbophil in irritable bowel syndrome (IBS) (2 arms), sponsored by Ningbo No. 2 Hospital. Primary endpoints: Abdominal discomfort or abdominal pain intensity and Bowel movement frequency. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
calcium polycarbophil
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on ChiCTR2600128405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128405.